troglitazone has been researched along with ursodoxicoltaurine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Chayama, K; Hyogo, H; Kanno, K; Nonaka, M; Tazuma, S | 1 |
2 other study(ies) available for troglitazone and ursodoxicoltaurine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
Topics: Apoptosis; Butadienes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Cytoprotection; Glycochenodeoxycholic Acid; Hepatocytes; Humans; JNK Mitogen-Activated Protein Kinases; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; Taurochenodeoxycholic Acid; Thiazolidinediones; Time Factors; Troglitazone | 2008 |